42. CLINICAL MANIFESTATIONS AND RELATED FACTORS OF VITILIGO AT THE NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY IN VIETNAM FROM 2016 TO 2017
Main Article Content
Abstract
Objectives: Examine clinical manifestations and associated factors of vitiligo patients at the National Hospital of Dermatology and Venereology (NHDV) from 2016 to 2017.
Materials and methods: A cross-sectional descriptive study of 80 patients diagnosed with vitiligo at the NHDV from 10/2016 to 9/2017.
Results: The average age of disease onset is 26.89 ± 18.38, of which the age group of 15 to 30 years old accounted for the highest proportion (40%). The incidence rate of women was higher than that of men (56.2% vs 43.8%). The rate of comorbidities explored via asking patient’s history was 17.5%, including gastric and duodenal ulcers, atopic dermatitis and allergic diseases, and history of thyroid disease was not reported. Patients with vitiligo having skin type IV accounted for 93.7% and skin type III accounted for 6.3%. The most common location of lesions was the face and neck, accounting for 46.3%, followed by the trunk (24.3%) and the extremities (1.5%). The main clinical type was non-segmental generalised vitiligo (46.3%) while the segmental type accounted for only 2.5%. Seventy one of 80 patients were in active disease stage (with VIDA score of +1,+2,+3,+4) accounting for 88.7%, in which VIDA score of +4 accounted for the highest proportion (38.7%).
Conclusion: In our study, vitiligo was common in young people, and the disease can occur in both men and women. The disease was mainly seen in patients with skin type IV and non-segmental generalised vitiligo was the most common form. A patient can have multiple lesion locations, and the mostly involved locations were face and neck.
Article Details
Keywords
Vitiligo, VIDA.
References
Fitzpatrick’s Dermatology in general medicine.
McGraw-Hill Medical Publishing Division,
2003, sixth edition, 839-847.
[2] C Bergqvist, K Ezzedine, Vitiligo: A Review,
Dermatology, 2020, 236, (6): 571–592.
[3] ML Dell’Anna, M Picardo, A review and a new
hypothesis for non-immunological pathogenetic
mechanisms in vitiligo, Pigment Cell Research,
2006, 19(5): 406–411.
[4] C Bergqvist, K Ezzedine, Vitiligo: A focus on
pathogenesis and its therapeutic implications, J
Dermatol, 2021, 48(3): 252–270.
[5] AM Dahir, SF Thomsen, Comorbidities in
vitiligo: comprehensive review, Int J Dermatol,
2018, 57(10):1157–1164.
[6] P Nimkar, A Wanjari, Vitiligo and the Role of
Newer Therapeutic Modalities, Cureus, 2022,
14(11): e31022.
[7] A Feily, Vitiligo Extent Tensity Index (VETI)
score: a new definition, assessment and treatment
evaluation criteria in vitiligo, Dermatol Pract
Concept, 2014, 4(4): 81–84.
[8] Vũ Mạnh Hùng, Nghiên cứu đặc điểm lâm sàng
và một số chỉ số miễn dịch trong bệnh bạch biến,
Luận án Tiến sĩ, Học Viện Quân Y, 2008.
[9] Phạm Thị Mai Hương, Nghiên cứu ảnh hưởng
của bệnh bạch biến đến chất lượng cuộc sống
người bệnh, Luận văn Thạc sĩ y học, Học viện
Quân Y, 2007.
[10] VN Sehgal, G Srivastava, Vitiligo: compendium
of clinico-epidemiological features, Indian J
Dermatol Venereol Leprol, 2007, 73(3): 149–
156.
[11] AN Onunu, EP Kubeyinje, Vitiligo in the
Nigerian African: a study of 351 patients in
Benin City, Nigeria, Int J Dermatol, 2003,
42(10): 800–802.
[12] E Nicolaidou et al., Childhood- and later-onset
vitiligo have diverse epidemiologic and clinical
characteristics, J Am Acad Dermatol, 2012,
66(6): 954–958.
[13] YH Kishan Kumar, GRR Rao, KVT Gopal et al.,
Evaluation of narrow-band UVB phototherapy
in 150 patients with vitiligo, Indian J Dermatol
Venereol Leprol, 2009, 75(2): 162–166.
[14] Handa S, Dogra S, Epidemiology of childhood
vitiligo: a study of 625 patients from north India,
Pediatr. Dermatol. 2003, 20(3): 207-210.
[15] J H Lee et al., Comorbidities in Patients with
Vitiligo: A Systematic Review and MetaAnalysis, J Invest Dermatol, 2023, 143(5): 777-
789.
[16] Vũ Mạnh Hùng, Tình hình, đặc điểm lâm sàng và
một số thay đổi miễn dịch trong bệnh bạch biến,
Luận văn Thạc sĩ y học, Học viện Quân y, 2002.
[17] D Zauli et al., Prevalence of autoimmune atrophic
gastritis in vitiligo, Digestion, 1986, 34(3): 169-
172.
[18] F Ghalamkarpour, MC André, Y Gauthier,
Shared histological and immunohistological
findings in two patients with generalized vitiligo
associated with autoimmune atrophic gastritis,
Clin Case Rep, 2022, 10(9): e6346.